Quantitative analysis of castration resistant prostate cancer progression through phosphoproteome signaling

被引：0
|
作者：
Reynald M Lescarbeau
David L Kaplan
机构：
[1] Tufts University,Department of Biomedical Engineering
来源：
BMC Cancer | / 14卷
关键词：
Prostate cancer; Phosphoproteome; Castration resistance; Regression analysis; Cell signaling;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] Nuclear receptor profiling in prostatospheroids and castration-resistant prostate cancer
    Wang, Zhu
    Wu, Dinglan
    Ng, Chi-Fai
    Teoh, Jeremy Yuen-Chun
    Yu, Shan
    Wang, Yuliang
    Chan, Franky L.
    ENDOCRINE-RELATED CANCER, 2018, 25 (01) : 35 - 50
  • [42] Targeting the androgen receptor in metastatic castration-resistant prostate cancer
    Aragon-Ching, Jeanny B.
    FUTURE ONCOLOGY, 2014, 10 (03) : 329 - 332
  • [43] New Therapies for Castration-Resistant Prostate Cancer: Efficacy and Safety
    Beltran, Himisha
    Beer, Tomasz M.
    Carducci, Michael A.
    de Bono, Johann
    Gleave, Martin
    Hussain, Maha
    Kelly, William K.
    Saad, Fred
    Sternberg, Cora
    Tagawa, Scott T.
    Tannock, Ian F.
    EUROPEAN UROLOGY, 2011, 60 (02) : 279 - 290
  • [44] The role of abiraterone in the management of metastatic castration-resistant prostate cancer
    Rawlinson, Alex
    Mohammed, Aza
    Beatty, John
    Bell, Richard
    Miller, Marek
    EXPERT REVIEW OF ANTICANCER THERAPY, 2012, 12 (04) : 429 - 437
  • [45] An update on TroVax® for the treatment of progressive castration-resistant prostate cancer
    Abern, Michael
    Kaufman, Howard L.
    Latchamsetty, Kalyan
    ONCOTARGETS AND THERAPY, 2011, 4 : 33 - 41
  • [46] Protocadherin 7 is overexpressed in castration resistant prostate cancer and promotes aberrant MEK and AKT signaling
    Shishodia, Gauri
    Koul, Weaty
    Koul, Hari K.
    PROSTATE, 2019, 79 (15) : 1739 - 1751
  • [47] Crosstalk Between AR and Wnt Signaling Promotes Castration-Resistant Prostate Cancer Growth
    Luo, Jun
    Wang, Dan
    Wan, Xuechao
    Xu, Yangguang
    Lu, Yali
    Kong, Zhe
    Li, Dujian
    Gu, Wei
    Wang, Chenji
    Li, Yao
    Ji, Chaoneng
    Gu, Shaohua
    Xu, Yaoting
    ONCOTARGETS AND THERAPY, 2020, 13 : 9257 - 9267
  • [48] Experience with octreotide depot in the treatment of castration-resistant prostate cancer
    Kolesnikov, G. P.
    ONKOUROLOGIYA, 2015, 11 (02): : 85 - 88
  • [49] The 5α-Androstanedione Pathway to Dihydrotestosterone in Castration-Resistant Prostate Cancer
    Sharifi, Nima
    JOURNAL OF INVESTIGATIVE MEDICINE, 2012, 60 (02) : 504 - 507
  • [50] TAK-441, a novel investigational smoothened antagonist, delays castration-resistant progression in prostate cancer by disrupting paracrine hedgehog signaling
    Ibuki, Naokazu
    Ghaffari, Mazyar
    Pandey, Mitali
    Iu, Irene
    Fazli, Ladan
    Kashiwagi, Masahide
    Tojo, Hideaki
    Nakanishi, Osamu
    Gleave, Martin E.
    Cox, Michael E.
    INTERNATIONAL JOURNAL OF CANCER, 2013, 133 (08) : 1955 - 1966
12345